Literature DB >> 9343120

Association between medial temporal lobe atrophy on CT and parietotemporal uptake decrease on SPECT in Alzheimer's disease.

I Lavenu1, F Pasquier, F Lebert, B Jacob, H Petit.   

Abstract

OBJECTIVES: Alzheimer's disease is the most frequent cause of degenerative dementia. Despite the available diagnostic criteria, improvement of diagnosic accuracy is still required. The aim of this prospective study was to assess in a large population of patients referred to a memory clinic the diagnostic value of the combination of medial temporal lobe atrophy on temporal oriented CT and decreased temporoparietal uptake on HMPAO single photon emission tomography (SPECT).
METHODS: The study was conducted in 125 patients aged 51-93: 64 with probable Alzheimer's disease (Mean (SD) mini mental state examination (MMSE)=18.34 (6.93)), duration of disease=6.48 (2.93) years, 13 possible Alzheimer's disease (MMSE=21.58 (5.48), duration of disease=6.08 (2.56)), 48 patients with miscellaneous memory disorders (MMSE=21.98 (6.10), duration the disease = 6.85 (3.91)).
RESULTS: For the diagnosis of probable Alzheimer's disease, the sensitivity of this association was 0.56, the specificity 0.93, the positive predictive value 0.95, and the negative predictive value 0.45. The diagnosic accuracy was 0.68. Both medial temporal atrophy and parietotemporal decrease in uptake were present in four of 13 patients with possible Alzheimer's disease and 11 of 48 with miscellaneous memory disorders. The association was absent in 27 of 29 patients with frontotemporal dementia. In mild stages (MMSE>18; n = 32), the sensitivity of the association was 0.34, the specificity 0.93, the positive predictive value 0.85, and the negative predictive value 0.57. The diagnosic accuracy was 0.53.
CONCLUSION: This association, although not sensitive, helps to select patients with high probability of Alzheimer's disease at an early stage which can be of interest for clinical and research purposes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343120      PMCID: PMC2169791          DOI: 10.1136/jnnp.63.4.441

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  43 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  The investigation of Alzheimer's disease with single photon emission tomography.

Authors:  A Burns; M P Philpot; D C Costa; P J Ell; R Levy
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

Review 3.  Primary progressive aphasia--differentiation from Alzheimer's disease.

Authors:  M M Mesulam
Journal:  Ann Neurol       Date:  1987-10       Impact factor: 10.422

4.  Determination of cerebral blood flow by SPECT: a valuable tool in the investigation of dementia?

Authors:  H C Weinstein; A Hijdra; E A van Royen; M M Derix
Journal:  Clin Neurol Neurosurg       Date:  1989       Impact factor: 1.876

5.  Technetium-99m HM-PAO-SPECT study of regional cerebral perfusion in early Alzheimer's disease.

Authors:  D Perani; V Di Piero; G Vallar; S Cappa; C Messa; G Bottini; A Berti; D Passafiume; G Scarlato; P Gerundini
Journal:  J Nucl Med       Date:  1988-09       Impact factor: 10.057

6.  Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease.

Authors:  T Arendt; V Bigl; A Tennstedt; A Arendt
Journal:  Neuroscience       Date:  1985-01       Impact factor: 3.590

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia.

Authors:  D Neary; J S Snowden; R A Shields; A W Burjan; B Northen; N MacDermott; M C Prescott; H J Testa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-09       Impact factor: 10.154

9.  Differential diagnosis in dementia using the cerebral blood flow agent 99mTc HM-PAO: a SPECT study.

Authors:  H G Gemmell; P F Sharp; J A Besson; J R Crawford; K P Ebmeier; J Davidson; F W Smith
Journal:  J Comput Assist Tomogr       Date:  1987 May-Jun       Impact factor: 1.826

10.  Posterior cortical atrophy.

Authors:  D F Benson; R J Davis; B D Snyder
Journal:  Arch Neurol       Date:  1988-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.